$ELTX

Top Midday Decliners

Idaho Copper (COPR) priced its underwritten public offering of stocks and warrants at $4.85 apiece, targeting about $18 million in gross proceeds, it said late Wednesday.The shares began trading on Thursday, down 34% amid intraday trading volume of about 415,000.Elicio Therapeutics' (ELTX) shares sank 34% after the company said Thursday it priced a registered direct offering of about 4.4 million shares.More than 3.43 million shares of the company traded intraday compared with a daily average of about 1.45 million.Ouster (OUST) priced an underwritten public offering of 3.62 million common shares at $55.22 apiece, for expected gross proceeds of about $200 million, the company said Thursday.Shares slumped 18%, with intraday trading volume at about 6.65 million versus a daily average of roughly 4.41 million.Price: $4.10, Change: $-2.15, Percent Change: -34.40%

Wall Street Set to Open Higher in Thursday Trading; US Adds Only 57,000 Jobs in June

US stocks look set to open higher in Thursday's trading session as investors parse key employment data released earlier in the morning.Dow Jones Industrial Average futures were up 0.3%, S&P 500 futures gained 0.2%, and Nasdaq futures rose 0.1%.Oil prices were heading sharply lower, with front-month global benchmarks Brent crude dropping 1.2% to $70.71 a barrel, while West Texas Intermediate crude was tumbling 1.4% to $67.60 a barrel.Investors are mulling over nonfarm payrolls, initial jobless claims, unemployment data, and average hourly earnings figures released by the US Bureau of Labor Statistics.US nonfarm payrolls rose only 57,000 in June, well below the 113,000 increase expected by analysts polled by Bloomberg and following a revised 129,000 gain in May. The unemployment rate for June declined to 4.2% from 4.3% in May, while Bloomberg expected the rate to remain unchanged.Initial jobless claims decreased to 215,000 in the week ended June 27 from a revised 216,000 the previous week, falling short of the 218,000 expected by analysts surveyed by Bloomberg. Average hourly earnings for June rose to 0.4% from 0.3%, compared with forecasts of 0.3%.In other world markets, Japan's Nikkei fell 2.5%, Hong Kong's Hang Seng rose 0.8%, and China's Shanghai Composite dropped 2%. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 was up 0.8%, Germany's DAX was rising 1.5%, and France's CAC was tracking 1.2% higher.In equities, shares of StablecoinX (USDE) soared 75% in Thursday's premarket session after the company said Thursday that it has launched its flagship infrastructure software platform StablecoinX Harness.SurgePays (SURG) shares were up 36% after the company said it amended an agreement with one of its tier 1 wholesale wireless network providers.Tenax Therapeutics (TENX) shares were rising almost 12% after the company said Thursday that results from a phase 3 clinical trial will be presented in a late-breaking clinical science session at the European Society of Cardiology Congress 2026.On the losing side, Linkhome (LHAI) shares were down 38% in Thursday premarket activity, following the previous session's 315% gain after the company announced the acquisition of Mortgage One Group.Elicio Therapeutics (ELTX) stock was down 32% after pricing a registered direct offering of about 4.4 million shares.INLIF (INLF) shares were down 26% after its board approved a 1-for-200 share combination.

Elicio Reports Complete Responses in 3 Pancreatic Cancer Patients After ELI-002 7P, Nivolumab Treatment

Elicio Therapeutics (ELTX) said Wednesday that three patients who received ELI-002 7P in the phase 2 Amplify-7P study and later experienced disease progression subsequently achieved complete radiographic and complete metabolic responses after receiving nivolumab-based therapy.The company said it intends to continue monitoring additional patients who participated in the Amplify-7P study and are currently following a similar course of treatment.Elicio said the findings support further evaluation of checkpoint inhibitor combinations and could help inform future development strategies in metastatic pancreatic ductal adenocarcinoma and the design of a planned phase 3 trial in adjuvant PDAC.Subject to funding, the company also plans to initiate a phase 1 study evaluating ELI-002 7P in combination with gemcitabine/nab-paclitaxel chemotherapy and an anti-PD-1 inhibitor in treatment-naive metastatic mKRAS pancreatic cancer.Price: $3.16, Change: $+0.40, Percent Change: +14.49%

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks declined late Monday afternoon with the NYSE Healthcare Index decreasing 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.7%.The iShares Biotechnology ETF (IBB) rose 0.6%.In corporate news, Centene (CNC) will offer buyouts to most employees to reduce costs after a slump in health-plan membership in the past year, Bloomberg reported. Centene shares fell 3.2%.Neumora Therapeutics (NMRA) shares tumbled 48% after the company halted development of its major depressive disorder treatment navacaprant after two Phase 3 trials failed to meet their primary and key secondary endpoints. Neumora also announced it will reduce its workforce by 35%.Elicio Therapeutics (ELTX) shares plunged 72% after the company said a Phase 2 study assessing the experimental pancreatic cancer therapy ELI-002 7p did not meet the prespecified primary endpoint of disease-free survival.Cuprina (CUPR) shares surged 102% after a subsidiary obtained 510(k) clearance from the US Food and Drug Administration for its Medifly Maggots product that uses Lucilia cuprina larvae in maggot debridement therapy.

Top Midday Decliners

Elicio Therapeutics (ELTX) said Monday its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p failed to meet the pre-specified primary endpoint of disease-free survival.Shares sank 72% after a surge in intraday trading volume to over 7.10 million from a daily average of about 131,000.Comtech Telecommunications (CMTL) agreed to sell most of its Satellite and Space Communications segment to Gilat Satellite Networks (GILT) for $157.5 million, the companies said in separate statements Monday.Shares of Comtech Telecommunications plummeted 43% as intraday trading volume climbed to more than 3.72 million, versus a daily average of about 297,000.Fox (FOX, FOXA) agreed to acquire Roku (ROKU) in a cash-and-stock deal that values the TV streaming platform at about $22 billion, creating a media and technology entity with one of the largest streaming businesses in the US.Fox shares dropped 16%, with intraday trading volume rising to more than 4.48 million from the stock's daily average of about 1.33 million.Price: $4.09, Change: $-10.77, Percent Change: -72.49%

Sector Update: Healthcare Stocks Softer Monday Afternoon

Healthcare stocks declined Monday afternoon with the NYSE Healthcare Index dropping 0.7% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.5%.The iShares Biotechnology ETF (IBB) rose 0.5%.In sector news, the Centers for Medicare & Medicaid Services proposed a rule to establish a permanent regulatory framework for the Medicare Drug Price Negotiation Program beginning with the 2029 price-applicability year, shifting to codified regulations from implementation through annual guidance.In corporate news, Neumora Therapeutics (NMRA) shares tumbled 52% after the company halted development of its major depressive disorder treatment navacaprant after two Phase 3 trials failed to meet their primary and key secondary endpoints. Neumora also announced it will reduce its workforce by 35%.Elicio Therapeutics (ELTX) shares plunged 72% after the company said a Phase 2 study assessing the experimental pancreatic cancer therapy ELI-002 7p did not meet the prespecified primary endpoint of disease-free survival.Cuprina Holdings (CUPR) shares more than doubled after a subsidiary obtained 510(k) clearance from the US Food and Drug Administration for its Medifly Maggots product that uses Lucilia cuprina larvae in maggot debridement therapy.

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) 0.6% higher.Precigen (PGEN) shares were up more than 3% after the company said the US Food and Drug Administration granted orphan drug exclusivity for its recurrent respiratory papillomatosis treatment called papzimeos.Zymeworks' (ZYME) drug to treat certain reproductive tract cancers has shown promise in early testing, the biotechnology company reported at the European Society for Medical Oncology Gynaecological Cancers Congress. Zymeworks stock was up more than 1% pre-bell.Elicio Therapeutics (ELTX) shares were down more than 64% after the company said its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p did not meet the pre-specified primary endpoint of disease-free survival.

B. Riley Initiates Elicio Therapeutics at Buy With $27 Price Target

Ladenburg Thalmann Initiates Elicio Therapeutics at Buy